Zions Bancorporation’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-46
Closed -$3.18K 941
2024
Q1
$3.18K Sell
46
-10
-18% -$633 ﹤0.01% 801
2023
Q4
$4.14K Buy
56
+10
+22% +$655 ﹤0.01% 763
2023
Q3
$3.14K Sell
46
-7
-13% -$594 ﹤0.01% 781
2023
Q2
$4.98K Buy
53
+7
+15% +$546 ﹤0.01% 729
2023
Q1
$3.12K Hold
46
﹤0.01% 784
2022
Q4
$2.28K Buy
+46
New +$1.88K ﹤0.01% 949
2022
Q2
Sell
-92
Closed -$6K 1085
2022
Q1
$6K Hold
92
﹤0.01% 914
2021
Q4
$7K Buy
92
+9
+11% +$794 ﹤0.01% 797
2021
Q3
$8K Sell
83
-17
-17% -$1.79K ﹤0.01% 765
2021
Q2
$12K Sell
100
-3
-3% -$358 ﹤0.01% 689
2021
Q1
$14K Sell
103
-8
-7% -$1.09K ﹤0.01% 633
2020
Q4
$15K Buy
111
+28
+34% +$3.39K ﹤0.01% 607
2020
Q3
$8K Hold
83
﹤0.01% 715
2020
Q2
$7K Sell
83
-108
-57% -$8.63K ﹤0.01% 691
2020
Q1
$11K Sell
191
-2,835
-94% -$230K ﹤0.01% 569
2019
Q4
$280K Sell
3,026
-168
-5% -$14.8K 0.04% 157
2019
Q3
$288K Buy
3,194
+448
+16% +$51K 0.04% 170
2019
Q2
$325K Buy
2,746
+254
+10% +$25.6K 0.05% 148
2019
Q1
$216K Buy
+2,492
New +$212K 0.03% 201

Other funds holding EXAS

Zions Bancorporation's EXAS Position: Q2 2024 in Review

Zions Bancorporation sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 46 shares — an estimated $3.18K sold.

Zions Bancorporation first reported a position in EXAS in Q1 2019 and held it in 19 quarters. The position peaked at $325K in Q2 2019. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Zions Bancorporation reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Zions Bancorporation sold 46 Exact Sciences shares in Q2 2024, an estimated $3.18K.
  • Zions Bancorporation first reported a position in Exact Sciences in Q1 2019 and held it in 19 quarters.
  • Zions Bancorporation's Exact Sciences position peaked at $325K in Q2 2019.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Zions Bancorporation's 13F filing for Q2 2024, filed 8 Aug 2024.